Mychaluk J, Perignon D, Qassemyar Q, Gianfermi M, Sinna R
Service de gynécologie obstétrique, centre hospitalier de Compiègne, 60200 Compiègne, France.
Ann Chir Plast Esthet. 2012 Feb;57(1):1-8. doi: 10.1016/j.anplas.2011.11.007. Epub 2012 Jan 13.
There is a new concern about a possible association between anaplastic large cell lymphoma (ALCL) and breast implants. The purpose of this review was to identify and analyze all reported cases of ALCL occurring in patients with breast implants. Therefore, we reviewed all articles published concerning this subject between 1991 and 2011. We found 41 cases of ALCL. The mean age of the patients was 51 years old with an average of 108 months between the implantation and the diagnosis. Over 60 % of the reported cases were aesthetic augmentations. However, none of the published study managed to highlight a correlation between the prosthesis and this lymphoma. Therefore, we believe that for the moment, we can reassure our patients, but we must be aware of this association if a late seroma or a tumefaction occur on prosthesis. The surgical management seems to be essential for the diagnosis and the treatment, especially by the negative ALK and CD 30 expression of this lymphoma.
间变性大细胞淋巴瘤(ALCL)与乳房植入物之间可能存在关联,这引发了新的关注。本综述的目的是识别和分析所有已报道的乳房植入物患者发生ALCL的病例。因此,我们查阅了1991年至2011年间发表的关于该主题的所有文章。我们发现了41例ALCL病例。患者的平均年龄为51岁,植入与诊断之间的平均间隔时间为108个月。超过60%的报道病例是美容隆胸。然而,已发表的研究均未能突出假体与这种淋巴瘤之间的相关性。因此,我们认为目前可以让患者放心,但如果假体出现晚期血清肿或肿胀,我们必须意识到这种关联。手术处理对于诊断和治疗似乎至关重要,特别是鉴于这种淋巴瘤的ALK和CD 30阴性表达。